SI1765085T1 - Sestavki, ki vsebujejo ženske zarodne matične celice in postopki njihove uporabe - Google Patents

Sestavki, ki vsebujejo ženske zarodne matične celice in postopki njihove uporabe

Info

Publication number
SI1765085T1
SI1765085T1 SI200532007T SI200532007T SI1765085T1 SI 1765085 T1 SI1765085 T1 SI 1765085T1 SI 200532007 T SI200532007 T SI 200532007T SI 200532007 T SI200532007 T SI 200532007T SI 1765085 T1 SI1765085 T1 SI 1765085T1
Authority
SI
Slovenia
Prior art keywords
compositions
methods
stem cells
germline stem
female germline
Prior art date
Application number
SI200532007T
Other languages
English (en)
Inventor
Jonathan L. Tilly
Joshua Johnson
Original Assignee
The General Hospital Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corporation filed Critical The General Hospital Corporation
Publication of SI1765085T1 publication Critical patent/SI1765085T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/43—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for artificial insemination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SI200532007T 2004-05-17 2005-05-17 Sestavki, ki vsebujejo ženske zarodne matične celice in postopki njihove uporabe SI1765085T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US57222204P 2004-05-17 2004-05-17
US57418704P 2004-05-24 2004-05-24
US58664104P 2004-07-09 2004-07-09
EP05782697.6A EP1765085B1 (en) 2004-05-17 2005-05-17 Compositions comprising female germline stem cells and methods of use thereof
PCT/US2005/017221 WO2005121321A2 (en) 2004-05-17 2005-05-17 Compositions comprising female germline stem cells and methods of use thereof

Publications (1)

Publication Number Publication Date
SI1765085T1 true SI1765085T1 (sl) 2015-11-30

Family

ID=35428927

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200532007T SI1765085T1 (sl) 2004-05-17 2005-05-17 Sestavki, ki vsebujejo ženske zarodne matične celice in postopki njihove uporabe

Country Status (14)

Country Link
US (7) US20060010509A1 (sl)
EP (5) EP2987855B1 (sl)
JP (3) JP2008512990A (sl)
AU (3) AU2005257839A1 (sl)
CA (6) CA2566857A1 (sl)
CY (1) CY1116768T1 (sl)
DK (1) DK1765085T3 (sl)
ES (1) ES2547953T3 (sl)
HK (1) HK1221975A1 (sl)
HU (1) HUE027620T2 (sl)
PL (1) PL1765085T3 (sl)
PT (1) PT1765085E (sl)
SI (1) SI1765085T1 (sl)
WO (3) WO2005113752A2 (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955846B2 (en) 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
JP2008512990A (ja) * 2004-05-17 2008-05-01 ザ ジェネラル ホスピタル コーポレーション 骨髄由来の生殖細胞系列幹細胞から生殖細胞を産生するための方法及び組成物
WO2007146106A2 (en) * 2006-06-05 2007-12-21 Cryo- Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
WO2007142651A1 (en) * 2006-06-09 2007-12-13 Caritas St. Elizabeth Medical Center Of Boston, Inc. Methods and compositions for the treatment of neuropathy
CZ299271B6 (cs) * 2007-03-14 2008-06-04 Ceská zemedelská univerzita v Praze Použití inhibitoru histon deacetylázy pro prípravu kultivacního média na prodloužení životnosti savcích oocytu in vitro
EP2178550A4 (en) * 2007-07-27 2010-08-04 Immuneregen Biosciences Inc METHODS AND COMPOSITIONS FOR STIMULATING THE PROLIFERATION OR DIFFERENTIATION OF STEM CELLS BY SUBSTANCE P OR AN ANALOGUE THEREOF
EP2022847A1 (en) * 2007-08-07 2009-02-11 Irma Virant-Klun Pluripotent stem cells, methods for their isolation and their use and culture media
CN102105579A (zh) * 2007-08-07 2011-06-22 普里梅真比奥特斯公司 生殖系干细胞的分离、表征和繁殖
WO2009042127A2 (en) * 2007-09-24 2009-04-02 The General Hospital Corporation Compositions and methods for rescuing fertility
AU2012242591B2 (en) 2011-04-14 2014-10-23 The General Hospital Corporation Compositions and methods for autologous germline mitochondrial energy transfer
EP2726601B1 (en) 2011-06-29 2018-12-26 The General Hospital Corporation Compositions and methods for enhancing bioenergetic status in female germ cells
CN102250830B (zh) * 2011-07-05 2013-01-16 西北农林科技大学 一种雌性生殖干细胞的体外分离及培养方法
US10271876B2 (en) * 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
CN105916977A (zh) * 2013-10-07 2016-08-31 东北大学 用于使用自体细胞系统从生殖系细胞离体产生有发育能力的卵的方法和组合物
CN107073036A (zh) 2014-03-27 2017-08-18 东北大学 用于卵巢卵泡生长和成熟的方法
TW201619194A (zh) 2014-09-16 2016-06-01 歐把科學股份有限公司 特異性結合至人類vasa蛋白質的抗體、抗體製劑、經分離核酸分子、細胞及分離表現vasa蛋白質的細胞的方法
JP6905714B2 (ja) * 2015-09-17 2021-07-21 学校法人東京農業大学 始原生殖細胞を機能的に成熟した卵母細胞へと分化させる培養方法
JP6754966B2 (ja) * 2016-02-25 2020-09-16 国立大学法人広島大学 始原生殖細胞の培養方法及び始原生殖細胞の培養用培地添加物
JP7021828B2 (ja) * 2017-11-10 2022-02-17 一公 川島 卵巣由来幹細胞の減数分裂誘導法
CN113355386B (zh) * 2021-06-02 2022-05-17 福建省妇幼保健院 一种应用三原核受精卵检测体外受精环境质量的方法
EP4358982A2 (en) * 2021-06-25 2024-05-01 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Primordial germ cells

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854470A (en) 1973-11-23 1974-12-17 L Augspurger Reproduction processes for cellular bodies
IT1057895B (it) 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
US4193392A (en) 1977-09-23 1980-03-18 Barnett Gordon R Method for removing ova from animals
US4326505A (en) 1980-01-07 1982-04-27 Occidental Petroleum Corporation Surgical procedure for embryo transplants on animals
US4339434A (en) 1981-08-17 1982-07-13 Gametrics Limited Method of increasing the incidence of female offspring
US4845077A (en) 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
FR2563726B1 (fr) 1984-05-04 1986-10-10 Robert Cassou Appareil d'insemination artificielle, notamment des carnivores
US4642094A (en) 1984-05-29 1987-02-10 North Jr Walter L Non-surgical embryo transfer device
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
FR2580933B1 (fr) 1985-04-24 1987-08-07 Lenck Lucien Capacite trans-uterine pour fecondation " in vitro in vivo "
FR2589879B1 (fr) 1985-11-08 1989-05-12 Claude Ranoux Conteneur pour culture anaerobie d'embryons humains
AT387718B (de) 1986-04-09 1989-03-10 Fischl Franz H Dr Katheder zur kuenstlichen befruchtung
FR2608037A1 (fr) 1986-12-10 1988-06-17 Lenck Lucien Methode d'intubation destinee a permettre la transplantation de l'oeuf ou de la matiere embryonnaire, et moyens pour sa mise en oeuvre
FR2609885B1 (fr) 1987-01-22 1989-04-14 Cassou Robert Instrument pour l'insemination artificielle, le transfert d'embryons ou le prelevement de liquides folliculaires chez les mammiferes
US5538948A (en) 1987-01-30 1996-07-23 Novo Nordisk A/S Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone
US4865589A (en) 1987-04-22 1989-09-12 Ludwig Simmet Instrument for the transfer of materials such as sperm and embryos
FR2614626B1 (fr) 1987-04-30 1989-07-21 Ranoux Claude Conteneur pour fecondation des ovocytes et replacement des embryons chez l'homme et l'animal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5160312A (en) 1990-02-09 1992-11-03 W. R. Grace & Co.-Conn. Cryopreservation process for direct transfer of embryos
US5147315A (en) 1990-04-06 1992-09-15 C. R. Bard, Inc. Access catheter and system for use in the female reproductive system
US5627066A (en) 1991-05-14 1997-05-06 Mount Sinai School Of Medicine Of The City University Of New York Method and apparatus for in vitro fertilization
AU2016392A (en) 1991-05-14 1992-12-30 Mount Sinai School Of Medicine Of The City University Of New York, The Method and apparatus for (in vitro) fertilization
FR2678506B1 (fr) 1991-07-01 2000-03-10 Claude Ranoux Procede de fecondation en cycle spontane.
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5750376A (en) 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US5744366A (en) 1992-05-01 1998-04-28 Trustees Of The University Of Pennsylvania Mesoscale devices and methods for analysis of motile cells
US5296375A (en) 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
GB9227123D0 (en) 1992-12-30 1993-02-24 Applied Research Systems Method
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
GB9305984D0 (en) 1993-03-23 1993-05-12 Royal Free Hosp School Med Predictive assay
US5360389A (en) 1993-05-25 1994-11-01 Chenette Philip E Methods for endometrial implantation of embryos
US5541081A (en) 1994-03-22 1996-07-30 President And Fellows Of Harvard College Process for assessing oocyte and embryo quality
GB9410639D0 (en) 1994-05-27 1994-07-13 Queen Mary & Westfield College Method of improving fertilization
JP3660026B2 (ja) 1995-09-04 2005-06-15 扶桑薬品工業株式会社 体外受精用培地組成物
US5827174A (en) 1995-09-26 1998-10-27 Reuss, Jr.; William Alexander Biological speciman containment and incubation pouch
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US6040340A (en) 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
US5824548A (en) 1996-05-29 1998-10-20 Wisconsin Alumni Research Foundation Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
US6251665B1 (en) 1997-02-07 2001-06-26 Cem Cezayirli Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
CA2199663C (en) 1997-03-11 2004-08-10 Ruth Miriam Moses In vitro maturation and fertilization of mammalian oocytes
US5935968A (en) 1997-03-17 1999-08-10 Merck & Co., Inc. Methods for treating polycystic ovary syndrome
US5961444A (en) 1997-10-17 1999-10-05 Medworks Corporation In vitro fertilization procedure using direct vision
US6010448A (en) 1997-10-17 2000-01-04 Medworks Corp Embryo transfer arrangement
US6196965B1 (en) 1998-05-21 2001-03-06 Cryofacets, Inc. Compositions methods and devices for embryo implantation for in vitro fertilization
US6485972B1 (en) 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
DE60025905T2 (de) 1999-02-24 2006-09-14 Novo Nordisk A/S In vitro methode zur synchronisation von oozytenreifung
EP1156821B1 (en) 1999-02-24 2007-05-02 Novo Nordisk A/S Treatment of infertility
CA2389117A1 (en) 1999-10-27 2001-05-03 Mount Sinai Hospital Methods and compositions for enhancing developmental potential of oocytes and zygotes
US6875854B1 (en) * 1999-11-18 2005-04-05 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
WO2001036445A1 (en) 1999-11-18 2001-05-25 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
US20020142457A1 (en) 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
US6395546B1 (en) 2000-02-01 2002-05-28 Neurogeneration, Inc. Generation of dopaminergic neurons from human nervous system stem cells
FR2812004B1 (fr) 2000-07-24 2002-12-27 Ccd Lab Milieux de culture pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons
CA2466198A1 (en) 2001-11-06 2003-05-15 Shanghai Second Medical University Somatic cell derived embryonic stem cells and their differentiated progenies
AUPR892501A0 (en) 2001-11-16 2001-12-13 Peter Maccallum Cancer Institute, The Method of enhancing self renewal of stem cells and uses thereof
US20030134422A1 (en) 2002-01-16 2003-07-17 Sayre Chauncey Bigelow Stem cell maturation for all tissue lines
US7390659B2 (en) 2002-07-16 2008-06-24 The Trustees Of Columbia University In The City Of New York Methods for inducing differentiation of embryonic stem cells and uses thereof
CA2493768A1 (en) 2002-07-23 2004-01-29 Nanodiagnostics, Inc. Embryonic stem cell markers and uses thereof
WO2005007687A1 (en) 2003-07-09 2005-01-27 Dana-Farber Cancer Institute, Inc Compositions and methods for modulating ovarian follicular initiation
US20050130302A1 (en) * 2003-09-29 2005-06-16 Reprocell Inc. Method and composition for regulating expansion of stem cells
JP2008512990A (ja) * 2004-05-17 2008-05-01 ザ ジェネラル ホスピタル コーポレーション 骨髄由来の生殖細胞系列幹細胞から生殖細胞を産生するための方法及び組成物
US7955846B2 (en) * 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
US20080050347A1 (en) * 2006-08-23 2008-02-28 Ichim Thomas E Stem cell therapy for cardiac valvular dysfunction
US8062222B2 (en) * 2007-06-13 2011-11-22 Litron Laboratories, Ltd. Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
US20090111764A1 (en) * 2007-10-25 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Mitochondrial selection
AU2012242591B2 (en) 2011-04-14 2014-10-23 The General Hospital Corporation Compositions and methods for autologous germline mitochondrial energy transfer

Also Published As

Publication number Publication date
US20060015961A1 (en) 2006-01-19
EP2987855B1 (en) 2018-11-21
EP1765983A2 (en) 2007-03-28
PL1765085T3 (pl) 2015-11-30
EP1765085A4 (en) 2008-11-12
US20190300852A1 (en) 2019-10-03
JP2008512990A (ja) 2008-05-01
CY1116768T1 (el) 2017-03-15
DK1765085T3 (en) 2015-10-05
WO2006001938A2 (en) 2006-01-05
US9267111B2 (en) 2016-02-23
EP1765085A2 (en) 2007-03-28
CA2841716C (en) 2020-01-07
EP1765985A2 (en) 2007-03-28
WO2005113752A2 (en) 2005-12-01
WO2005113752A3 (en) 2007-06-07
EP1765983A4 (en) 2008-10-22
HK1221975A1 (zh) 2017-06-16
EP1765985A4 (en) 2008-10-15
JP2008512989A (ja) 2008-05-01
US20160362657A1 (en) 2016-12-15
CA2569031A1 (en) 2006-01-05
CA2566851A1 (en) 2005-12-22
AU2005245899A1 (en) 2005-12-01
CA2566857A1 (en) 2005-12-01
CA2566851C (en) 2015-11-10
WO2005121321A2 (en) 2005-12-22
JP2007537754A (ja) 2007-12-27
PT1765085E (pt) 2015-10-20
US20060010509A1 (en) 2006-01-12
AU2005257839A1 (en) 2006-01-05
CA2897658A1 (en) 2005-12-22
EP3498827A1 (en) 2019-06-19
WO2005121321A3 (en) 2006-09-28
WO2006001938A3 (en) 2006-10-12
AU2005252636A1 (en) 2005-12-22
EP2987855A1 (en) 2016-02-24
ES2547953T3 (es) 2015-10-09
US20160137978A1 (en) 2016-05-19
CA2841716A1 (en) 2005-12-01
CA3009909A1 (en) 2005-12-22
US20120195861A1 (en) 2012-08-02
HUE027620T2 (en) 2016-10-28
EP1765085B1 (en) 2015-07-08
US20190352602A1 (en) 2019-11-21

Similar Documents

Publication Publication Date Title
EP1765085A4 (en) COMPOSITIONS WITH FEMALE GERMAN STEM CELLS AND METHOD OF USE THEREOF
HRP20182133T1 (hr) Pripravci koji sadrže azelastin i postupci njihove upotrebe
EP1730261A4 (en) COMPOSITIONS AND METHODS FOR GROWING EMBRYONIC STEM CELLS
IL177587A0 (en) Batteries and methods of manufacture and uses thereof
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
EP1909644A4 (en) INSERTION APPARATUS AND METHODS OF USE
EP1827464A4 (en) ZINC COMPOSITIONS AND METHODS OF USE
IL190885A0 (en) Immunogenic compositions and methods of use
IL180437A0 (en) Shape and dimension maintenance of soft tissue grafts by stem cells
EP1945137A4 (en) PARTLY COVERED STENT DEVICES AND APPLICATION METHODS
AP2008004623A0 (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
IL172689A0 (en) Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
IL181370A0 (en) Non-protein foaming compositions and methods of making the same
IL182943A0 (en) Ovr110 antibody compositions and methods of use
EP1735456A4 (en) POYLMERIC COMPOSITIONS AND ASSOCIATED METHODS OF USE
EP1745012A4 (en) COMPOSITIONS OF ALLOSTERIC HEMOGLOBIN MODIFYING SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF
EP1778210A4 (en) CONJUGATES OF FATTY ACID AND AMINO ACIDS AND METHODS OF USE
EP1718732A4 (en) METHODS OF MAKING AND USING SKIN DERIVED STEM CELLS
ZA200606545B (en) Chronotherapeutic compositions and methods of their use
EP1627912A4 (en) PREPARATION OF ENDODERMAL STEM CELLS
EP1933805A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
EP1740120A4 (en) LONG-TERM FORMULATIONS OF NALTREXONE AND METHOD OF USE
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
EP1765321A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE THEREOF
EP1730199A4 (en) COMPOSITION BASED ON NATIVE CELL WALLS AND METHOD OF USE